Citations 1
P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL-DERIVED PEPTIDE THERAPEUTIC VACCINE, AS MONOTHERAPY AND IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB, FOR TREATMENT OF PATIENTS WITH INDOLENT NHL
Zinzani, P. L., Ansell, S. M., Bosch, F., Friedberg, Jonathan W. , Marolleau, Jean Pierre, Arcaini, L., Gopal, A. K., Grande, C., Merryman, R., Pinto, A., Smith, S. D., Wallace, D., Fagerberg, J., Magalhaes, J. G., Armand, P., Zinzani, Pier Luigi , Ansell, Stephen M., García‐Sánz, Ramón , Gopal, A., Pinto, A., Villasboas, José C. , Fagerberg, J., Magalhaes, J. Gamelas
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 1005-1006
